Northwell Health Fertility

Manhasset, New York 11030

Medical Director: Christine M. Mullin, MD

Northwell Health Fertility in Manhasset, New York, offers comprehensive reproductive care under the guidance of Medical Director Christine M. Mullin, MD. The clinic provides a full range of fertility services including IVF, egg freezing, donor egg programs, and surrogacy options, giving you multiple pathways to build your family. Their laboratory maintains verified accreditation, ensuring the highest standards of care for your treatment.

The numbers speak to their expertise: patients under 35 have a 55.90% live birth rate, while those ages 35-37 achieve a 41.90% success rate. With 2,016 treatment cycles performed in 2022, the team brings substantial experience to each patient's unique journey. Understanding that fertility treatment can feel overwhelming, Northwell Health Fertility focuses on providing clear guidance and personalized care throughout your experience. Their comprehensive approach means you can access different treatment options under one roof, allowing your care team to adapt your treatment plan as your needs evolve.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Donor Egg

Uses eggs from a screened donor for patients who cannot use their own.

Surrogacy

Gestational carrier arrangements — an embryo is transferred to a surrogate who carries the pregnancy.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3555.90%+7.556.90%48.4%
35–3741.90%+5.950.50%36%
38–4028.50%+4.949.00%23.6%
Over 408.80%-0.721.00%9.5%

Based on 2,016 total cycles reported. National averages computed across all reporting clinics.

Physicians

Nearby Clinics

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.